Hosted on MSN
Expect further innovation in cancer therapies: AstraZeneca Pharma India's Praveen Rao Akkinepally
Global biopharmaceutical company AstraZeneca is strengthening focus on areas such as oncology, cardiovascular, renal, rare diseases, and the emerging GLP-1 segment. In September, it announced its ...
Get all latest & breaking news on Astrazeneca Pharma India. Watch videos, top stories and articles on Astrazeneca Pharma ...
AstraZeneca India enhances employee health benefits with a new Rs 25 lakh cancer-care insurance covering employees and their dependents, effective July 1, 2026. This is an additional layer over ...
Get the latest news today on Astrazeneca Pharma India Ltd. Follow Business Standard for the complete news coverage and key ...
Mumbai, Nov. 18 -- The agreement aims to accelerate access to SZC, an innovative treatment for hyperkalaemia, across the country. Hyperkalaemia, a clinically significant condition, disproportionately ...
Drug firm AstraZeneca on Wednesday said it has launched a clinical data and insights division in India for data-related management of its clinical trials. The Bengaluru-based clinical data and ...
LONDON (Reuters) - AstraZeneca Plc is considering options for its Indian unit, including buying the remaining 10 percent of AstraZeneca Pharma India Ltd in order to secure full ownership in a key ...
AstraZeneca has begun a legal challenge against a demand by India's National Pharmaceutical Pricing Authority (NPPA) for payment in relation to alleged overcharging. NPPA has accused AstraZeneca of ...
Up to five million British people will be unable to travel into Europe this summer after being given a batch of the AstraZeneca Covid vaccine that was made in India. These particular shots aren’t yet ...
Get all latest & breaking news on Astrazeneca India. Watch videos, top stories and articles on Astrazeneca India at moneycontrol.com.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results